All Stories

  1. Type 2 Diabetes Mellitus Increases the Risk to Hip Fracture in Postmenopausal Osteoporosis by Deteriorating the Trabecular Bone Microarchitecture and Bone Mass
  2. An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials
  3. An update on therapies for the treatment of diabetes-induced osteoporosis
  4. Novel biological therapies for the treatment of diabetic foot ulcers
  5. Terbufos sulfone aggravates kidney damage in STZ-induced diabetic rats
  6. Chronic Complications of Diabetes Mellitus: A Mini Review
  7. Recent Progress in the Use of Glucagon and Glucagon Receptor Antagonists in the Treatment of Diabetes Mellitus
  8. Evaluating the Phase II drugs currently under investigation for diabetic neuropathy
  9. Mechanism of the beneficial and protective effects of exenatide in diabetic rats
  10. Medicinal Chemistry of Novel Anti-Diabetic Drugs
  11. Medicinal Chemistry of the Anti-Diabetic Effects of Momordica Charantia: Active Constituents and Modes of Actions
  12. Amylin Analogues in the Treatment of Diabetes Mellitus: Medicinal Chemistry and Structural Basis of its Function
  13. Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
  14. Chronic Experimental Diabetes Accelerates Urinary Elimination of Deprenyl and its Metabolites